Topic

Articles

Avance Clinical’s acquisition of C3 Research Associates expands its CRO services to North America.


Avance Clinical Acquires C3 Research Associates

Roche’s acquisition of Good Therapeutics grants them rights to the company's conditionally activated PD-1-regulated IL-2 program.

Roche to Acquire Good Therapeutics for $250 Million

SIRIO is enhancing its strategy for small and medium nutrition brands as Lonza’s Sara Lesina joins as GM in Europe.

SIRIO Enhances Company Strategy with Addition of Lonza’s Sara Lesina

Novo Nordisk’s $1.1 billion acquisition of Forma Therapeutics is intended to expand its sickle cell and rare blood disorder portfolio.

Novo Nordisk to Acquire Forma Therapeutics for $1.1 Billion

Emma Frank is an associate at Wolf, Greenfield & Sacks, P.C.

The Hatch Waxman safe harbor provision exempts otherwise infringing uses of patented materials if they are in furtherance of a regulatory submission, but the use of patented research tools may fall outside its protection.

Protecting Both  Intellectual Property and Progress

 Washington Editor, jillwechsler7@gmail.com.

Pharma loses battle to block price negotiations, but implementation faces many challenges.

New Legislation Overhauls Medicare Drug Pricing and Benefits

Mike Hennessy Jr. is the President and CEO of 

While the cost of certain medicines are alarmingly high, they can be considered a bargain measured against a lifetime of traditional costs.

What Does Cost Mean?

Moderna is suing Pfizer and BioNTech for allegedly infringing on patents the company filed from 2010 to 2016.

Moderna Files Suit Against Pfizer and BioNTech

ChargePoint Technology has acquired single-use container company PuroVaso.

ChargePoint Technology Acquires PuroVaso

ProBioGen will collobarate with NextPoint Therapeutics  to develop and manufacture its lead antibody candidate.

BioBusiness